1. Home
  2. AGYS vs SUPN Comparison

AGYS vs SUPN Comparison

Compare AGYS & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agilysys Inc.

AGYS

Agilysys Inc.

HOLD

Current Price

$73.44

Market Cap

3.3B

Sector

Technology

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$54.75

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGYS
SUPN
Founded
1963
2005
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
2.8B
IPO Year
1994
2010

Fundamental Metrics

Financial Performance
Metric
AGYS
SUPN
Price
$73.44
$54.75
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$128.33
$61.60
AVG Volume (30 Days)
356.2K
769.2K
Earning Date
01-01-0001
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.93
N/A
Revenue
$275,624,000.00
$392,755,000.00
Revenue This Year
$17.65
$8.18
Revenue Next Year
$14.36
$22.15
P/E Ratio
$79.05
N/A
Revenue Growth
16.07
N/A
52 Week Low
$63.71
$29.16
52 Week High
$144.82
$59.68

Technical Indicators

Market Signals
Indicator
AGYS
SUPN
Relative Strength Index (RSI) 30.57 63.28
Support Level N/A $47.95
Resistance Level $119.60 $57.65
Average True Range (ATR) 3.79 2.16
MACD 0.32 0.47
Stochastic Oscillator 25.32 55.19

Price Performance

Historical Comparison
AGYS
SUPN

About AGYS Agilysys Inc.

Agilysys Inc provides hospitality software delivering cloud-native SaaS and on-premise solutions for hotels, resorts, cruise lines, casinos, corporate foodservice management, restaurants, universities, stadiums, and healthcare facilities. The company's software solutions include point-of-sale (POS), property management (PMS), inventory and procurement, payments, and related applications that manage and enhance the entire guest journey. It derives maximum revenue from the provision of software subscription and maintenance services, followed by the provision of professional services, and the sale of products (proprietary software licenses, third-party hardware, and operating systems). Agilysys operates across North America, Europe, the Middle East, Asia-Pacific, and India.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: